Latest News
| Gilead Announces Second Quarter 2008 Financial Results | ![]() |
News
- Read Gilead's 2007 Annual Report
- Gilead Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV
- Gilead Sciences Announces Second Quarter 2008 Financial Results
- Gilead Sciences to Release Second Quarter 2008 Financial Results on Thursday, July 17, 2008
- View all news



